Dagmar Kulms

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Intellectual Disability

Top Venues

Cell death & disease

Science advances

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou, Christiane Margue, Ali Kishk, Greta Del Mistro, Luca Di Leo, Maria Moscardó Garcia, Rashi Halder, Lasse Sinkkonen, Daniela De Zio, Stephanie Kreis, Dagmar Kulms, Thomas Sauter
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma. Cell death & disease 14 (7) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Luise Dunsche, Nikita Ivanisenko, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Cristian Angeli, Stephanie Kreis, Mahvash Tavassoli, Inna Lavrik, Dagmar Kulms
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma. Cell death & disease 14 (12) (2023)
Greta Del Mistro, Shamala Riemann, Sebastian Schindler, Stefan Beissert, Roland E Kontermann, Aurelien Ginolhac, Rashi Halder, Luana Presta, Lasse Sinkkonen, Thomas Sauter, Dagmar Kulms
Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma. Cell death & disease 13 (1) (2022)
Marco Albrecht, Yuri Kogan, Dagmar Kulms, Thomas Sauter
Mechanistically Coupled PK (MCPK) Model to Describe Enzyme Induction and Occupancy Dependent DDI of Dabrafenib Metabolism. Pharmaceutics 14 (2) (2022)
Truong San Phan, Leonhard Schink, Jasmin Mann, Verena M Merk, Pascale Zwicky, Sarah Mundt, Dagmar Simon, Dagmar Kulms, Susanne Abraham, Daniel F Legler, Mario Noti, Thomas Brunner
Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Science advances 7 (5) (2021)
Antonella Montinaro, Itziar Areso Zubiaur, Julia Saggau, Anna-Laura Kretz, Rute M M Ferreira, Omar Hassan, Ella Kitzig, Ines Müller, Mona A El-Bahrawy, Silvia von Karstedt, Dagmar Kulms, Gianmaria Liccardi, Johannes Lemke, Henning Walczak
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers. Cell death and differentiation (2021)